About us
Translating scientific breakthroughs into breakthrough products
Synthetic Genomics Inc. (SGI) is a global leader in the fields of synthetic biology and synthetic genomics utilizing our foundational intellectual property in these rapidly evolving disciplines to design and build biological systems to solve global sustainability challenges.
SGI provides solutions in genomics research, bioproduction, and applied products. Our research segment is focused on genomics solutions for academic and commercial R&D organizations. The commercial products and services include instrumentation, reagents, DNA synthesis services, and bioinformatics services and software.
SGI’s efforts in bio-based production are targeted at improving existing biological production hosts and developing entirely new synthetic production hosts with the goal of more efficient production of pharmaceuticals, vaccines, nutritionals, and bio-industrial products derived from renewable biological resources. Our host systems can also enable entirely new products that were once not scientifically or economically viable.
SGI’s “understanding of life” allows us to address many challenges, from non-GMO food products to complex biological design and engineering projects in biotechnology. Our applied products are typically done in partnership with leading global organizations across a variety of industries.
Translating world-first innovations into disruptive, sustainable solutions for researchers, companies and consumers.
Leadership
A team with a track record of commercializing breakthroughs
Synthetic Genomics Inc. is a synthetic biology company founded to commercialize genomic-driven technologies. Our strength lies in the decades of pioneering research by our founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific, technology and business teams they have assembled. Our team has a proven track record of making scientific breakthroughs that translate into viable commercial solutions.
Board of Directors
Synthetic Genomics is guided by visionary Board members who have built industries
J. Craig Venter, Ph.D.
Co-Founder, Chairman, Co-Chief Scientific Officer; Co-Founder, Chairman and Chief Executive Officer – Human Longevity, Inc; Founder, Chairman, and CEO – J. Craig Venter Institute
Barry Schuler
Chairman and CEO of Raydiance, Inc.; Managing Director of Draper Fisher Jurvetson Growth Fund
Hamilton O. Smith, M.D.
Co-Founder, Co-Chief Scientific Officer; Scientific Director of the J. Craig Venter Institute
